El-Osta Austen, Liu Vivian N, Huang David, Foster Jeff, Johnson Hans, Alaa Aos, Hayhoe Benedict
Self-Care Academic Research Unit (SCARU), School of Public Health, Imperial College London, London, UK.
Menwell Ltd., London, UK.
Transl Androl Urol. 2025 May 30;14(5):1295-1307. doi: 10.21037/tau-2024-738. Epub 2025 May 27.
Prevalence of late-onset testosterone deficiency (TD) ranges between 6-30% depending on diagnostic criteria. Recent data highlights various benefits of testosterone replacement therapy (TRT), including increased libido, mood, bone mineral density, and lean body mass. This study investigated the personal experiences of men with TD around low testosterone and TRT, including barriers to accessing TRT.
Previous or current TRT users were recruited via email from private clinics' emailing lists, professional medical organisations and researchers' professional networks. Participants completed a 52-item structured questionnaire on Qualtrics XM, exploring their perceptions and experiences of TRT on their symptoms and quality of life. Associations between demographics, duration of symptoms and effectiveness were assessed using logistic regressions.
Among the 905 men on TD treatment, 86% delayed treatment for at least a year, including 24% who experienced symptoms for over 5 years before seeking care. Older men (aged 51+ years) were 1.61 times more likely to delay treatment. The majority (85%) reported TRT as effective or very effective, with longer-term users 2.6 times more likely to report TRT as very effective compared to recent starters. Primary motivations for seeking TRT included improving personal relationships (79%) and physical appearance (53%). Most (81%) relied on online sources for information; fewer (18%) felt comfortable discussing hormonal health with their peers. Patient expectations during medical consultations focused on diagnosis (77%), treatment options (64%) and learning about potential side effects (51%). The most common side effects were acne (24%), testicular shrinkage (24%) and nipple itchiness/gynaecomastia (19%). TRT users reported notable improvements in overall quality of life (75%), mental wellbeing (71%), self-esteem and self-confidence (69%) and appearance (61%).
A significant proportion of men aged over 50 years surveyed reported experiencing prolonged symptoms of TD prior to seeking care. There is a need for greater awareness and education regarding TD symptoms, including streamlining timely and equitable access to effective treatment options.
根据诊断标准,迟发性睾酮缺乏(TD)的患病率在6%至30%之间。近期数据凸显了睾酮替代疗法(TRT)的多种益处,包括性欲增强、情绪改善、骨矿物质密度增加以及瘦体重增加。本研究调查了患有TD的男性在睾酮水平低下及接受TRT方面的个人经历,包括获取TRT的障碍。
通过电子邮件从私人诊所的邮件列表、专业医学组织和研究人员的专业网络中招募既往或当前的TRT使用者。参与者在Qualtrics XM上完成了一份包含52个条目的结构化问卷,探讨他们对TRT对其症状和生活质量影响的认知和体验。使用逻辑回归评估人口统计学、症状持续时间与疗效之间的关联。
在接受TD治疗的905名男性中,86%的人延迟治疗至少一年,其中24%的人在寻求治疗前症状持续超过5年。年龄较大的男性(51岁及以上)延迟治疗的可能性是其他人的1.61倍。大多数人(85%)报告TRT有效或非常有效,与近期开始治疗的人相比,长期使用者报告TRT非常有效的可能性高出2.6倍。寻求TRT的主要动机包括改善人际关系(79%)和外貌(53%)。大多数人(81%)依靠在线资源获取信息;较少人(18%)愿意与同龄人讨论激素健康问题。患者在医疗咨询期间的期望集中在诊断(77%)、治疗选择(64%)以及了解潜在副作用(51%)。最常见的副作用是痤疮(24%)、睾丸萎缩(24%)和乳头瘙痒/男性乳房发育(19%)。TRT使用者报告在总体生活质量(75%)、心理健康(71%)、自尊和自信(69%)以及外貌(61%)方面有显著改善。
接受调查的50岁以上男性中有很大一部分报告在寻求治疗前经历了长时间的TD症状。需要提高对TD症状的认识和教育,包括简化及时、公平地获得有效治疗方案的途径。